-+ 0.00%
-+ 0.00%
-+ 0.00%

Allogene Therapeutics Initiates Pivotal Phase 2 ALPHA3 Trial for Cema-Cel in Large B-Cell Lymphoma

Reuters·08/13/2025 20:11:19

Please log in to view news